Nordson appoints Dr. Milton Morris to board of directors

NORDSON CORP

Dr. Milton Morris, recently retired CEO of Neuspera Medical, elected to board effective Sept 15, 2022; will serve on Audit Committee.
Morris brings medical device innovation experience; board cites potential to support Nordson's expansion in medical devices via acquisitions.
Morris replaces departing director Arthur George, bringing board to nine members.
He received prorated compensation and 79 RSUs under the company's stock plan; independence confirmed.

item 5.02 item 8.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Dr. Milton M. Morris

Director

NDSN · NORDSON CORP

Effective: 2022-09-15
Filed: September 15, 2022, 7:59 PM ET

On September 15, 2022, the Board of Directors (the “Board”) of Nordson Corporation (the “Company”) elected Dr. Milton M. Morris as a Director

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Dr. Milton M. Morris was elected as Director at NORDSON CORP.

Action: elected
Role: Director

Exact text from the filing

On September 15, 2022, the Board of Directors (the “Board”) of Nordson Corporation (the “Company”) elected Dr. Milton M. Morris as a Director

View on SEC.gov

NORDSON CORP filing history →

Source: SEC EDGAR

accession 0000072331-22-000094

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.